Are Jubilant Pharmova’s US Plant Closure, FDA Observations At Canada Unit A Concern?

The US FDA’s observations at its radiopharma manufacturing facility in Canada could be a headwind for Jubilant Pharmova, but reorientation of US generics manufacturing is expected to boost profits. Scrip takes a look at the likely impact.